PTLA - Portola Pharmaceuticals (PTLA) CEO Scott Garland on Q3 2018 Results - Earnings Call Transcript
Portola Pharmaceuticals (PTLA)
Q3 2018 Earnings Conference Call
November 7, 2018 4:30 PM ET
Executives
Cara Miller - Vice President of Investor Relations and Corporate Communications
Scott Garland - President and Chief Executive Officer
Mardi Dier - Executive Vice President, Chief Financial Officer
John Curnutte - Executive Vice President, Research & Development
Jeet Mahal - Vice President of Marketing and Business Development
Analysts
Dana Flanders - Goldman Sachs
Yigal Nochomovitz - Citigroup
Matthew Phipps - William Blair & Co.
Jay Olson - Oppenheimer & Co. Inc.
Vamil Divan - Credit Suisse
Kenneth Atkins - Cowen